Sublocade Alternatives Compared
| Sublocade (buprenorphine) | Buprenorphine | Brixadi (buprenorphine) |
|
|---|
| Sublocade (buprenorphine) | Buprenorphine | Brixadi (buprenorphine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Sublocade is a once-monthly injection that may be used to treat adults with opioid use disorder and is administered subcutaneously (under the skin) into the abdomen. It forms a depot under the skin... View more |
Prescription only
Buprenorphine is a potent analgesic that should be only used to treat moderate to severe pain or for the treatment of opioid addiction under strict conditions. Different formulations of the drug... View more |
Prescription only
Prescribed for Opiate Dependence - Maintenance, Opioid Use Disorder. Brixadi may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
| More about Sublocade (buprenorphine) | More about Buprenorphine | More about Brixadi (buprenorphine) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Sublocade has an average rating of 7.9 out of 10 from a total of 300 ratings on Drugs.com. 74% of reviewers reported a positive effect, while 14% reported a negative effect. |
Buprenorphine has an average rating of 6.7 out of 10 from a total of 1133 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 25% reported a negative effect. |
Brixadi has an average rating of 7.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
|
None |
None |
|||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Sublocade prices |
View all Buprenorphine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other buprenorphine brands include: Belbuca, Brixadi, Buprenex, Butrans | Belbuca, Brixadi, Buprenex, Butrans, Sublocade | Other buprenorphine brands include: Belbuca, Buprenex, Butrans, Sublocade | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
48 hours |
48 hours |
48 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 693 drugs are known to interact with Sublocade:
|
A total of 693 drugs are known to interact with Buprenorphine:
|
A total of 693 drugs are known to interact with Brixadi:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
November 30, 2017 |
December 29, 1981 |
May 23, 2023 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.